Literature DB >> 10414651

Schizophrenia and sudden death: a medical examiner case study.

D Chute1, C Grove, B Rajasekhara, J E Smialek.   

Abstract

This study reviews the causes of sudden death of 66 schizophrenic patients who presented to the Office of the Chief Medical Examiner (OCME) for the State of Maryland over a 3-year period from 1994 through 1996. We identified an increased incidence of suicide compared with the general population of OCME cases. This observation is consistent with reports by other investigators. The majority of the deaths were the result of natural diseases, mostly atherosclerotic cardiovascular disease. Accidents, suicides, and 1 homicide were also present in this group.

Entities:  

Mesh:

Year:  1999        PMID: 10414651     DOI: 10.1097/00000433-199906000-00005

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  5 in total

1.  Schizophrenia and anaesthesia.

Authors:  Liew Sat Lin Constance; Meryl Grace Lansing; Foo Kiang Khor; Rajesh Kumar Muniandy
Journal:  BMJ Case Rep       Date:  2017-11-23

Review 2.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

Review 3.  A review of olanzapine-associated toxicity and fatality in overdose.

Authors:  Pierre Chue; Peter Singer
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

4.  Emergency anaesthetic management of a severely anaemic, chronic schizophrenic patient with history of neuroleptic malignant syndrome.

Authors:  Shrividya Chellam; Dhanwanti S Rajwade; Snehlata O Tavri
Journal:  Indian J Anaesth       Date:  2011-11

5.  Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia.

Authors:  Yohko Iwamoto; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Mami Fujibayashi; Chie Ishii; Norio Ishii; Toshio Moritani; Masataka Taguri; Yoshio Hirayasu
Journal:  BMC Psychiatry       Date:  2012-11-14       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.